Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1801PDF: 1419HTML: 328 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8364PDF: 5767HTML: 87223Fig.1b: 142Fig.1c: 140Fig.2a: 124Fig.2b: 134Fig.4: 152Fig.2c: 134Fig.3: 148Tab.1: 189Tab.2: 160Tab.3: 156Tab.4: 175Fig1a: 138 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3875PDF: 965HTML: 3394Untitled: 154Cneo. Fig.1: 84Untitled: 81Untitled: 103Untitled: 97 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4408PDF: 1247HTML: 1812Untitled: 147Untitled: 143 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2601PDF: 1141HTML: 2559Figure 1: 126 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2551PDF: 761HTML: 6422Untitled: 176Untitled: 143Untitled: 145Untitled: 155 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3061PDF: 1373HTML: 3956 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1573PDF: 736HTML: 10139Figures 1,2,3: 133 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2314PDF: 760HTML: 8708Efremov 1: 160Efremov 2: 137 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2564PDF: 925HTML: 5478 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2556PDF: 975HTML: 3220 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3009PDF: 2530HTML: 175 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2073PDF: 1252HTML: 16957Bassan Fig.1: 118Bassan Fig.2: 117Bassan Fig.4: 101Fig.3: 142 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3689PDF: 1794HTML: 5114Table 1: 156 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2982PDF: 1262HTML: 2486 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4169PDF: 2529HTML: 2172 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2065PDF: 816HTML: 1921Fig 1 Rossi: 123 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1325PDF: 1055HTML: 155 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2855PDF: 778HTML: 7094Kost Fig1: 135Kost Fig 2: 126Kost Fig3: 124Kost Fig 4: 130Kost Fig5: 131Kost fig 6: 115 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1385PDF: 922HTML: 86 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
2990PDF: 855HTML: 2896 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
2916PDF: 1026HTML: 1651 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3361PDF: 791HTML: 6674 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
913PDF: 629HTML: 180 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1201PDF: 707HTML: 917 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2301PDF: 783HTML: 17407Fig1 Caligaris: 113Fig.2 Caliga: 152 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
1888PDF: 1087HTML: 3630 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2696PDF: 1347HTML: 3023Cover Letter: 161 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3515PDF: 1356HTML: 9141Untitled: 239Untitled: 131Untitled: 128Untitled: 127Untitled: 143Untitled: 285 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1412PDF: 754HTML: 639







